Last $0.69 HKD
Change Today 0.00 / 0.00%
Volume 0.0
As of 4:01 AM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

tianjin teda biomedical-h (8189) Snapshot

Open
$0.69
Previous Close
$0.69
Day High
$0.69
Day Low
$0.69
52 Week High
02/10/14 - $1.03
52 Week Low
08/27/14 - $0.57
Market Cap
979.8M
Average Volume 10 Days
60.5K
EPS TTM
$0.01
Shares Outstanding
705.0M
EX-Date
--
P/E TM
40.7x
Dividend
--
Dividend Yield
--
Current Stock Chart for TIANJIN TEDA BIOMEDICAL-H (8189)

Related News

No related news articles were found.

tianjin teda biomedical-h (8189) Related Businessweek News

No Related Businessweek News Found

tianjin teda biomedical-h (8189) Details

Tianjin TEDA Biomedical Engineering Company Limited, together with its subsidiaries, engages in the research and development, and commercialization of biological compound fertilizer products and health care products in the People’s Republic of China. It also provides combined, mixed, and plant fertilizers. The company markets its biological compound fertilizer products under the Fulilong brand. In addition, it offers a series of health care products under the Alpha brand comprising diabetic health care products and related products with the function of regulating the blood sugar level; and various series of sugar-free products, including beverages, cookies, cereals, and mooncakes. The company was founded in 2000 and is headquartered in Tianjin, the People's Republic of China.

560 Employees
Last Reported Date: 03/25/14
Founded in 2000

tianjin teda biomedical-h (8189) Top Compensated Officers

Executive Chairman, Chief Executive Officer, ...
Total Annual Compensation: CNY485.6K
Vice Chairman
Total Annual Compensation: CNY447.2K
Qualified Accountant and Company Secretary
Total Annual Compensation: CNY150.0K
Supervisor
Total Annual Compensation: CNY93.9K
Supervisor
Total Annual Compensation: CNY70.4K
Compensation as of Fiscal Year 2013.

tianjin teda biomedical-h (8189) Key Developments

Tianjin TEDA Biomedical Engineering Company Limited Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

Tianjin TEDA Biomedical Engineering Company Limited reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the six months, the company reported profit attributable to owners of the company of RMB 9,545,517 or 0.67 cents per basic share on turnover of RMB 276,956,208 compared to profit attributable to owners of the company of RMB 12,172,846 or 0.86 cents per basic share on turnover of RMB 319,365,053 for the last year. Profit before income tax expenses was RMB 10,138,601 compared to RMB 12,945,157 for the last year. Net cash used in operating activities was RMB 25,498,525 against RMB 24,916,601 a year ago. Purchases of property, plant and equipment was RMB 7,159,476 against RMB 1,665,242 a year ago. For the quarter, the company reported profit attributable to owners of the company of RMB 5,388,355 or 0.38 cents per basic share on turnover of RMB 140,050,205 compared to profit attributable to owners of the company of RMB 1,902,555 or 0.13 cents per basic share on turnover of RMB 147,221,412 for the last year. Profit before income tax expenses was RMB 5,990,214 compared to RMB 2,462,119 for the last year.

Tianjin TEDA Biomedical Engineering Company Limited to Report First Half, 2014 Results on Aug 07, 2014

Tianjin TEDA Biomedical Engineering Company Limited announced that they will report first half, 2014 results on Aug 07, 2014

Tianjin TEDA Biomedical Engineering Company Limited, Board Meeting, Aug 07, 2014

Tianjin TEDA Biomedical Engineering Company Limited, Board Meeting, Aug 07, 2014., at 16:00 China Standard Time. Agenda: To consider and approve the half-yearly unaudited results of the company and its subsidiaries for the six months ended 30 June 2014; to approve the draft announcement of the half-yearly unaudited results of the group to be published on the website of the growth enterprise market of The Stock Exchange of Hong Kong Limited; to consider the payment of interim dividend, if any; to consider the closure of the register of shareholders, if necessary; and to consider and approve other matters, if any.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8189:HK $0.69 HKD 0.00

8189 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 8189.
View Industry Companies
 

Industry Analysis

8189

Industry Average

Valuation 8189 Industry Range
Price/Earnings 41.8x
Price/Sales 1.4x
Price/Book 3.7x
Price/Cash Flow 41.8x
TEV/Sales 1.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TIANJIN TEDA BIOMEDICAL-H, please visit www.bioteda.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.